Jivan Moaddeb

560 total citations
21 papers, 461 citations indexed

About

Jivan Moaddeb is a scholar working on Pediatrics, Perinatology and Child Health, Geriatrics and Gerontology and Pharmacology. According to data from OpenAlex, Jivan Moaddeb has authored 21 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pediatrics, Perinatology and Child Health, 12 papers in Geriatrics and Gerontology and 11 papers in Pharmacology. Recurrent topics in Jivan Moaddeb's work include Pharmaceutical studies and practices (15 papers), Pharmaceutical Practices and Patient Outcomes (12 papers) and Pharmacogenetics and Drug Metabolism (11 papers). Jivan Moaddeb is often cited by papers focused on Pharmaceutical studies and practices (15 papers), Pharmaceutical Practices and Patient Outcomes (12 papers) and Pharmacogenetics and Drug Metabolism (11 papers). Jivan Moaddeb collaborates with scholars based in United States. Jivan Moaddeb's co-authors include Susanne B. Haga, Rachel Mills, Nancy M. Allen LaPointe, Alex Cho, Geoffrey S. Ginsburg, Hayden B. Bosworth, Matthew J. Crowley, William E. Kraus, Leah L. Zullig and Christopher B. Granger and has published in prestigious journals such as Medical Care, Journal of General Internal Medicine and Pharmacogenetics and Genomics.

In The Last Decade

Jivan Moaddeb

20 papers receiving 436 citations

Peers

Jivan Moaddeb
Mary W Roederer United States
Shanna K. O’Connor United States
Natasha Petry United States
Karl F. Gumpper United States
Narith N. Ou United States
PC Hannaford United Kingdom
Mary W Roederer United States
Jivan Moaddeb
Citations per year, relative to Jivan Moaddeb Jivan Moaddeb (= 1×) peers Mary W Roederer

Countries citing papers authored by Jivan Moaddeb

Since Specialization
Citations

This map shows the geographic impact of Jivan Moaddeb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jivan Moaddeb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jivan Moaddeb more than expected).

Fields of papers citing papers by Jivan Moaddeb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jivan Moaddeb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jivan Moaddeb. The network helps show where Jivan Moaddeb may publish in the future.

Co-authorship network of co-authors of Jivan Moaddeb

This figure shows the co-authorship network connecting the top 25 collaborators of Jivan Moaddeb. A scholar is included among the top collaborators of Jivan Moaddeb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jivan Moaddeb. Jivan Moaddeb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bosworth, Hayden B., Uptal D. Patel, Allison A. Lewinski, et al.. (2024). Clinical Outcomes Among High-Risk Primary Care Patients With Diabetic Kidney Disease. Medical Care. 62(10). 660–666.
2.
Haga, Susanne B., Rachel Mills, Jivan Moaddeb, Yiling Liu, & Deepak Voora. (2021). Independent Community Pharmacists’ Experience in Offering Pharmacogenetic Testing. Pharmacogenomics and Personalized Medicine. Volume 14. 877–886. 11 indexed citations
3.
Haga, Susanne B., Rachel Mills, Jivan Moaddeb, Yiling Liu, & Deepak Voora. (2021). Delivery of Pharmacogenetic Testing with or without Medication Therapy Management in a Community Pharmacy Setting. Pharmacogenomics and Personalized Medicine. Volume 14. 785–796. 3 indexed citations
4.
Zullig, Leah L., Clemontina A. Davenport, Clarissa J. Diamantidis, et al.. (2019). Primary Care Providers’ Acceptance of Pharmacists’ Recommendations to Support Optimal Medication Management for Patients with Diabetic Kidney Disease. Journal of General Internal Medicine. 35(1). 63–69. 6 indexed citations
5.
Haga, Susanne B. & Jivan Moaddeb. (2019). Pharmacogenomics Courses in Pharmacy School Curricula. Pharmacogenomics. 20(9). 625–630. 32 indexed citations
6.
Diamantidis, Clarissa J., Hayden B. Bosworth, Clemontina A. Davenport, et al.. (2018). Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) study: Protocol and baseline characteristics of a randomized controlled trial. Contemporary Clinical Trials. 69. 28–39. 19 indexed citations
7.
Haga, Susanne B., Jivan Moaddeb, Rachel Mills, & Deepak Voora. (2017). Assessing Feasibility of Delivering Pharmacogenetic Testing in a Community Pharmacy Setting. Pharmacogenomics. 18(4). 327–335. 13 indexed citations
8.
Haga, Susanne B., Rachel Mills, Jivan Moaddeb, et al.. (2017). Primary Care Providers’ Use of Pharmacist Support for Delivery of Pharmacogenetic Testing. Pharmacogenomics. 18(4). 359–367. 27 indexed citations
9.
Haga, Susanne B., Rachel Mills, & Jivan Moaddeb. (2016). Evaluation of a Pharmacogenetic Educational Toolkit for Community Pharmacists. Pharmacogenomics. 17(14). 1491–1502. 14 indexed citations
10.
Haga, Susanne B., Rachel Mills, Jivan Moaddeb, et al.. (2016). Patient Experiences with Pharmacogenetic Testing in a Primary Care Setting. Pharmacogenomics. 17(15). 1629–1636. 41 indexed citations
11.
Haga, Susanne B. & Jivan Moaddeb. (2016). Proposal for a Pharmacogenetics Certificate Program for Pharmacists. Pharmacogenomics. 17(6). 535–539. 5 indexed citations
12.
Zullig, Leah L., Walid F. Gellad, Jivan Moaddeb, et al.. (2015). Improving diabetes medication adherence: successful, scalable interventions. Patient Preference and Adherence. 9. 139–139. 64 indexed citations
13.
Moaddeb, Jivan, Rachel Mills, & Susanne B. Haga. (2015). Community pharmacists’ experience with pharmacogenetic testing. Journal of the American Pharmacists Association. 55(6). 587–594. 38 indexed citations
14.
Haga, Susanne B., et al.. (2015). Incorporation of Pharmacogenetic Testing into Medication Therapy Management. Pharmacogenomics. 16(17). 1931–1941. 36 indexed citations
15.
Mills, Rachel, et al.. (2014). Pharmacogenetic information for patients on drug labels. Pharmacogenomics and Personalized Medicine. 7. 297–297. 13 indexed citations
16.
Haga, Susanne B. & Jivan Moaddeb. (2014). Comparison of delivery strategies for pharmacogenetic testing services. Pharmacogenetics and Genomics. 24(3). 139–145. 40 indexed citations
17.
Haga, Susanne B., Nancy M. Allen LaPointe, Alex Cho, et al.. (2014). Pilot Study of Pharmacist-Assisted Delivery of Pharmacogenetic Testing in a Primary Care Setting. Pharmacogenomics. 15(13). 1677–1686. 28 indexed citations
18.
Haga, Susanne B., et al.. (2014). Pilot Study: Incorporation of Pharmacogenetic Testing in Medication Therapy Management Services. Pharmacogenomics. 15(14). 1729–1737. 10 indexed citations
19.
Moaddeb, Jivan & Susanne B. Haga. (2013). Pharmacogenetic testing: current evidence of clinical utility. Therapeutic Advances in Drug Safety. 4(4). 155–169. 27 indexed citations
20.
Moaddeb, Jivan, et al.. (2011). Hypertensive Urgency Associated With Xenadrine EFX Use. Journal of Pharmacy Practice. 24(4). 400–403. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026